Search research articles
Contact Us
Filters
Showing results (11-20 of 124) with videos related to
Page
of 13
Sort By:
Toxicon : Official Journal of the International Society on Toxinology
|
November 25, 2017
Immune drug discovery from venoms
Rocio Jimenez, Maria P Ikonomopoulou, J Alejandro Lopez, et al.
British Journal of Haematology
|
August 29, 2012
Tracking the repertoire of human adult and neonatal T cells during ex vivo amplification
Michelle A Neller, Andrew K Sewell, Scott R Burrows, et al.
Molecular Immunology
|
December 7, 2010
Real time detection of peptide-MHC dissociation reveals that improvement of primary MHC-binding residues can have a minimal, or no, effect on stability
Kim M Miles, John J Miles, Florian Madura, et al.
Scientific Reports
|
March 22, 2021
The medicinal plant Tabebuia impetiginosa potently reduces pro-inflammatory cytokine responses in primary human lymphocytes
Rachael Y M Ryan, Alejandra Fernandez, Yide Wong, et al.
Journal of Cancer Research and Clinical Oncology
|
October 27, 2021
Estimating the global burden of Epstein-Barr virus-related cancers
Yide Wong, Michael T Meehan, Scott R Burrows, et al.
Immunology
|
November 3, 2011
Structural and biophysical determinants of αβ T-cell antigen recognition
John S Bridgeman, Andrew K Sewell, John J Miles, et al.
Annual Review of Immunology
|
December 11, 2014
T cell antigen receptor recognition of antigen-presenting molecules
Jamie Rossjohn, Stephanie Gras, John J Miles, et al.
Marine Drugs
|
June 2, 2021
The Geographic Distribution, Venom Components, Pathology and Treatments of Stonefish (<i>Synanceia</i> spp.) Venom
Silvia L Saggiomo, Cadhla Firth, David T Wilson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 14, 2016
Molecular Pathways: Targeting CD96 and TIGIT for Cancer Immunotherapy
Stephen J Blake, William C Dougall, John J Miles, et al.
Diabetes
|
January 2, 2015
Reactivated CD4+Tm cells of T1D patients and siblings display an exaggerated effector phenotype with heightened sensitivity to activation-induced cell death
Michael Lei Bian, Oscar Haigh, David Munster, et al.
Page
of 13
Search research articles
Search
Showing results (11-20 of 124) with videos related to
Sort By:
Page
of 13
Toxicon : Official Journal of the International Society on Toxinology
|
November 25, 2017
Immune drug discovery from venoms
Rocio Jimenez, Maria P Ikonomopoulou, J Alejandro Lopez, et al.
British Journal of Haematology
|
August 29, 2012
Tracking the repertoire of human adult and neonatal T cells during ex vivo amplification
Michelle A Neller, Andrew K Sewell, Scott R Burrows, et al.
Molecular Immunology
|
December 7, 2010
Real time detection of peptide-MHC dissociation reveals that improvement of primary MHC-binding residues can have a minimal, or no, effect on stability
Kim M Miles, John J Miles, Florian Madura, et al.
Scientific Reports
|
March 22, 2021
The medicinal plant Tabebuia impetiginosa potently reduces pro-inflammatory cytokine responses in primary human lymphocytes
Rachael Y M Ryan, Alejandra Fernandez, Yide Wong, et al.
Journal of Cancer Research and Clinical Oncology
|
October 27, 2021
Estimating the global burden of Epstein-Barr virus-related cancers
Yide Wong, Michael T Meehan, Scott R Burrows, et al.
Immunology
|
November 3, 2011
Structural and biophysical determinants of αβ T-cell antigen recognition
John S Bridgeman, Andrew K Sewell, John J Miles, et al.
Annual Review of Immunology
|
December 11, 2014
T cell antigen receptor recognition of antigen-presenting molecules
Jamie Rossjohn, Stephanie Gras, John J Miles, et al.
Marine Drugs
|
June 2, 2021
The Geographic Distribution, Venom Components, Pathology and Treatments of Stonefish (<i>Synanceia</i> spp.) Venom
Silvia L Saggiomo, Cadhla Firth, David T Wilson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 14, 2016
Molecular Pathways: Targeting CD96 and TIGIT for Cancer Immunotherapy
Stephen J Blake, William C Dougall, John J Miles, et al.
Diabetes
|
January 2, 2015
Reactivated CD4+Tm cells of T1D patients and siblings display an exaggerated effector phenotype with heightened sensitivity to activation-induced cell death
Michael Lei Bian, Oscar Haigh, David Munster, et al.
Page
of 13